Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Chijan Zuo

Chijan Zuo

Vice President of R&D CureMed Biopharma

Seminars

Tuesday 21st July 2026

CircRNA-Based Potential Therapeutics for Tumor Therapy & Autoimmune Diseases

2:30 pm

Clean-PIE circRNA platform of CureMed
cmRNA1210: CircRNA based IL-12 for solid tumor
CircRNA based in vivo TCE/CAR-T

Chijan Zuo - 6th mRNA-Based Therapeutics Summit Speaker

View all Speakers

View Event Brochure